Status:
COMPLETED
β-cell Function in Type 1 Diabetes May Not Be As Low As Presumed
Lead Sponsor:
Gonca Incemehmet Tamer
Conditions:
TYPE 1 DIABETES
Eligibility:
All Genders
18-70 years
Brief Summary
Enhancing endogenous insulin production in type 1 diabetic patients (T1DP) can improve glycemic control and decrease complications and rates of mortality. However, it can be succesfull even if suffici...
Detailed Description
Background and aims: Enhancing endogenous insulin production in type 1 diabetic patients (T1DP) can improve glycemic control and decrease complications and rates of mortality. However, it can be succe...
Eligibility Criteria
Inclusion
- Type 1 diabetic patients who have accepted to have mixed meal tolarance test
Exclusion
- Patients with type 2 diabetes,
- patients with MODY
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT02199470
Start Date
April 1 2013
End Date
March 1 2015
Last Update
September 5 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medeniyet University Goztepe Training and Research Hospital
Istanbul, Turkey (Türkiye), 34730